Reuters: Health
The U.S. Food and Drug Administration on Thursday approved a sublingual film from Sunovion Pharmaceuticals Inc, a unit of Japan-based Sumitomo Dainippon Pharma , for the treatment of "off" episodes in patients with Parkinson's disease, the company said.
No comments:
Post a Comment